BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25560385)

  • 1. Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanism.
    León B; Navarro G; Dickey BJ; Stepan G; Tsai A; Jones GS; Morales ME; Barnes T; Ahmadyar S; Tsiang M; Geleziunas R; Cihlar T; Pagratis N; Tian Y; Yu H; Linington RG
    Org Lett; 2015 Jan; 17(2):262-5. PubMed ID: 25560385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
    Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
    Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.
    Manson McManamy ME; Hakre S; Verdin EM; Margolis DM
    Antivir Chem Chemother; 2014 Jan; 23(4):145-9. PubMed ID: 24318952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and challenges in the use of latent HIV-1 reactivating agents.
    Shang HT; Ding JW; Yu SY; Wu T; Zhang QL; Liang FJ
    Acta Pharmacol Sin; 2015 Aug; 36(8):908-16. PubMed ID: 26027656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Reactivates Latent HIV through Increasing Histone Acetylation and Activating Heat Shock Factor 1.
    Zeng X; Pan X; Xu X; Lin J; Que F; Tian Y; Li L; Liu S
    J Agric Food Chem; 2017 Jun; 65(22):4384-4394. PubMed ID: 28471170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.
    Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ
    AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on Abyssomicins: Inhibitors of the Chorismate Pathway and Folate Biosynthesis.
    Sadaka C; Ellsworth E; Hansen PR; Ewin R; Damborg P; Watts JL
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29882815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor.
    Lim H; Kim KC; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Virus Res; 2017 Jan; 227():1-5. PubMed ID: 27677464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism.
    Díaz L; Martínez-Bonet M; Sánchez J; Fernández-Pineda A; Jiménez JL; Muñoz E; Moreno S; Álvarez S; Muñoz-Fernández MÁ
    Sci Rep; 2015 Jul; 5():12442. PubMed ID: 26199173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
    Mejia EJ; Loveridge ST; Stepan G; Tsai A; Jones GS; Barnes T; White KN; Drašković M; Tenney K; Tsiang M; Geleziunas R; Cihlar T; Pagratis N; Tian Y; Yu H; Crews P
    J Nat Prod; 2014 Mar; 77(3):618-24. PubMed ID: 24495105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, structure, absolute stereochemistry, and HIV-1 integrase inhibitory activity of integrasone, a novel fungal polyketide.
    Herath KB; Jayasuriya H; Bills GF; Polishook JD; Dombrowski AW; Guan Z; Felock PJ; Hazuda DJ; Singh SB
    J Nat Prod; 2004 May; 67(5):872-4. PubMed ID: 15165153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
    Lin S; Zhang Y; Ying H; Zhu H
    Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
    Laird GM; Bullen CK; Rosenbloom DI; Martin AR; Hill AL; Durand CM; Siliciano JD; Siliciano RF
    J Clin Invest; 2015 May; 125(5):1901-12. PubMed ID: 25822022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latency reversal and viral clearance to cure HIV-1.
    Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
    Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis of abyssomicin C, atrop-abyssomicin C, and abyssomicin D: implications for natural origins of atrop-abyssomicin C.
    Nicolaou KC; Harrison ST
    J Am Chem Soc; 2007 Jan; 129(2):429-40. PubMed ID: 17212423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Polyketides with an Oxygen-Bridged Cyclooctadiene Core Skeleton from the Mangrove Endophytic Fungus Phomosis sp. A818.
    Zhang W; Zhao B; Du L; Shen Y
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28906443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine Spirotetronates: Biosynthetic Edifices That Inspire Drug Discovery.
    Braddock AA; Theodorakis EA
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog.
    Doyon G; Zerbato J; Mellors JW; Sluis-Cremer N
    AIDS; 2013 Jan; 27(2):F7-F11. PubMed ID: 22739395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.